000 01205 a2200325 4500
005 20250515035029.0
264 0 _c20060822
008 200608s 0 0 eng d
022 _a0002-9173
024 7 _a10.1309/4X8H-VJFK-PHXJ-YMFK
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLum, Gifford
245 0 0 _aEvaluation of a protocol to control utilization of B-type natriuretic peptide testing.
_h[electronic resource]
260 _bAmerican journal of clinical pathology
_cAug 2006
300 _a190-4 p.
_bdigital
500 _aPublication Type: Evaluation Study; Journal Article
650 0 4 _aCost-Benefit Analysis
650 0 4 _aDelivery of Health Care
_xstatistics & numerical data
650 0 4 _aDiagnostic Tests, Routine
_xeconomics
650 0 4 _aHealth Expenditures
650 0 4 _aHeart Failure
_xblood
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aNatriuretic Peptide, Brain
_xblood
650 0 4 _aPractice Guidelines as Topic
650 0 4 _aUtilization Review
650 0 4 _aVeterans
773 0 _tAmerican journal of clinical pathology
_gvol. 126
_gno. 2
_gp. 190-4
856 4 0 _uhttps://doi.org/10.1309/4X8H-VJFK-PHXJ-YMFK
_zAvailable from publisher's website
999 _c16479398
_d16479398